What is a healthy ApoB level?
There is no fixed 'healthy' ApoB value, but below 82 mg/dL the risk of a stroke already decreases measurably. ApoB offers better protection than LDL alone, but discuss your personal target with your doctor, as it depends on your overall risk profile and any medication you may be taking.
There is no fixed universal threshold, but a large Danish study of more than 104,000 people shows that the risk of ischaemic stroke already rises measurably above 82 mg/dL. As many as 16.3% of all ischaemic strokes in that group were associated with ApoB above that level. By comparison, elevated LDL cholesterol explained only 6.8%. That makes 82 mg/dL a useful threshold to keep in mind.
A Polish hospital study of nearly 10,600 patients used 100 mg/dL as the cut-off for 'elevated'. The median value in that group was 78 mg/dL. Patients with the highest cardiovascular risk had on average lower values, most likely due to lipid-lowering medication. This shows that 'normal' in hospital data is already shaped by treatment.
ApoB measures something different from LDL cholesterol. LDL tells you how much cholesterol is carried inside harmful fat particles. ApoB counts the actual number of those particles. In nearly a quarter of the Polish patients, ApoB gave a different picture than LDL. If you have many small, cholesterol-poor LDL particles, your LDL may look 'normal' while your ApoB is too high.
ApoB is also a better gauge of the effect of treatment. A meta-analysis of 27 studies showed that the reduction in ApoB was most strongly associated with shrinkage of narrowings in the coronary arteries, more so than the reduction in LDL or non-HDL cholesterol. Targeting ApoB therefore appears more effective if you want to reverse arterial hardening.
At a young age the consequences are not always visible yet. A small study of 13 children and young adults with a hereditary condition that structurally raises ApoB found no demonstrable arterial hardening or vascular stiffness. Because of the small number of participants, this provides no certainty about long-term risk.
The claims are based on two cohort studies (more than 104,000 and nearly 10,600 participants), one meta-analysis of 27 studies on plaque regression, and one small study of 13 carriers of a hereditary mutation. No large randomised trials on ApoB target values were included. The evidence is associative; for plaque regression, causality is considered probable on the basis of the meta-analysis.
What does your ApoB value tell you about your risk of cardiovascular disease?
ApoB gives a more accurate picture of your cardiovascular disease risk than standard LDL cholesterol. Ask your doctor to also measure ApoB (and possibly Lp(a)), especially if you have doubts about your risk profile.
How do you lower an ApoB level that is too high?
An ApoB level that is too high is very treatable, and several proven agents are available. Statins are the first choice; PCSK9 inhibitors offer the strongest reduction when statins are insufficient or not tolerated.
Who should have their ApoB measured?
Measuring ApoB is worthwhile for more people than current guidelines suggest: not only in cases of elevated blood fats, but also with excess weight, diabetes, familial hypercholesterolaemia, women after menopause, and people already taking cholesterol-lowering medication.
Is ApoB more important than regular cholesterol (LDL)?
ApoB consistently predicts cardiovascular disease better than LDL cholesterol. If you want to know how high your risk truly is, ask your doctor to measure ApoB alongside the standard cholesterol panel.
How early in life should you start lowering your LDL cholesterol to prevent cardiovascular disease?
Starting as early as possible pays off: LDL damage accumulates from childhood, and every year that your LDL remains lower counts. If familial high cholesterol runs in your family, discuss with your doctor whether screening from a young age makes sense.
What does a low-carbohydrate diet do to your LDL cholesterol in the long term?
A low-carbohydrate diet raises LDL in the short term, but that effect often disappears after a year; the effect on triglycerides and HDL is more favourable, but what this means for your long-term heart disease risk has not yet been proven.